Skip to Main Content

Advertisement

Skip Nav Destination

Molecular monitoring during dose reduction predicts recurrence after TKI cessation in CML

Blood (2020) 135 (10): 766–769.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement